Swiss Garnier has a strong, efficient and highly expertise research & development (R&D) team to support development of formulation.

We see tremendous value in investing in research & development (R&D). Our core strength lies in our ability to excel in developing generics and technologically complex products through focused teams in formulations and analytical development. The ability to develop formulations by using the latest and innovative technologies is the key differentiating factor of our research.

We have the capability to deliver quality products within established timelines, at low costs and without compromising on quality. Our scientists work closely with our business development team to generate innovative concepts and ideas, exploiting both market needs and synergies across therapeutic areas. Our research capability has not only paid us rich dividends in terms of business but also earned for us an enviable reputation for quality and capability in the pharma industry.

Manned by eminent researchers with years of experience and a horde of proven data in the store, the company has developed specialties in sustained release and extended release dosage forms with spectacular success.

Some of our unique product developments are mentioned below: -